Search

everythinglearnresearchcommunity

for

Search:↓

Pregnancy right after giving birth in mice lacking IL-10 causes milk that leads to liver issues and hair loss in their babies.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

LRIG1 is linked to better survival in Merkel cell carcinoma.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

miR-26b-5p in macrophage exosomes helps keloids grow.

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Loss of Pten in certain hair follicle stem cells increases skin cancer risk.

Bimekizumab quickly improves psoriasis symptoms and skin at the molecular level.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

A new IL6ST gene variant may cause a unique form of hyper-IgE syndrome with skin abscesses and high IgE levels.

Researchers found a new mutation in the LIPH gene of a woman with a rare hair condition.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Keeping human skin stem cells is easier with low temperatures and mTOR inhibition.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

A patient developed a blister at the injection site after hepatitis C treatment.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Targeting Interleukin-13 could help treat alopecia areata linked with atopic dermatitis.

miR-200c-3p could help diagnose and treat alopecia areata.

NLRP1 helps melanoma tumors grow by boosting inflammasome activation and reducing caspase-3 activity.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.